Is BMO a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Bank of Montreal (BMO) rests on The return-on-equity repair plan: At its Investor Day on March 26, 2026, BMO laid out a path to a sustained return on equity above 15% exiting fiscal 2027, bridged by roughly 250 basis points of core operating improvement on about 6% revenue growth per year, around 100 basis points from credit normalising, and around 50 basis points from share repurchases. The bear case rests on the largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in. Analysts covering it publish targets from $144.51 to $182.39 against a $169.74 share price on November 16, 2026, so even the professionals disagree by 23% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

BMO key stats

At $169.74 on November 16, 2026, Bank of Montreal (BMO) has a market cap of $118B, a P/E of 19.2 on trailing earnings (14.5 on forward earnings) and a dividend yield of 2.85%. It next reports earnings on December 2, 2026.

Market cap
$118B
P/E (trailing)
19.2
P/E (forward)
14.5
EPS (trailing 12 months)
$8.85
Price to book
2.0
Dividend yield
2.85%
Beta
1.12
Next earnings
December 2, 2026

Market cap, P/E and yield are measured at the $169.74 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Bank of Montreal (BMO)?

The last two weeks for Bank of Montreal, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • BMO closed at $169.74 on November 16, 2026, down 2.5% over the past five trading days (from $174.08).
  • Bank of Montreal next reports quarterly results on December 2, 2026.

Bank of Montreal filed no current, quarterly or annual report with the SEC in the last two weeks.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Bank of Montreal is Canada's oldest bank, founded in 1817, with its head office in Montreal and executive offices in Toronto. Management describes it as the eighth largest bank in North America by assets, with roughly $1.5 trillion CAD of total assets as of April 30, 2026, and about 53,200 employees. The business runs in five reporting segments: Canadian Personal and Commercial Banking, U.S. Banking, Wealth Management, Capital Markets and Corporate Services. The US franchise is unusually large for a Canadian bank, built on the old Harris Bank in Chicago and expanded materially by the 2023 purchase of Bank of the West, which added a California and Western US branch network. BMO reports under IFRS in Canadian dollars on an October fiscal year end, which means the quarter labelled Q3 fiscal 2026 ended July 31, 2026. The investment picture in October 2026 is a bank two years into fixing a return problem it created for itself. Credit costs on the US commercial book spiked through fiscal 2024 and 2025 and pushed reported ROE down to 10.6% for fiscal 2025, well below what the Canadian Big Six normally earn. Provisions are now falling, fee income across Capital Markets and Wealth Management is growing, and every segment posted record pre-provision pre-tax earnings in Q3 fiscal 2026. That quarter, reported August 25, produced adjusted net income of $2,859 million CAD (up 19%) and adjusted EPS of $3.96 CAD (up 22%), ahead of the roughly $3.76 consensus and the fourth straight quarterly beat. Adjusted ROE reached 14.0%. Reported results went the other way: a $962 million CAD after-tax charge ($1,092 million pre-tax), mostly goodwill, on the agreed sale of Transportation Finance and Vendor Finance to Stonepeak cut reported net income 25% to $1,750 million CAD and reported ROE to 8.4%. At the March 2026 Investor Day, management committed to a sustained ROE above 15% exiting fiscal 2027. The market re-rated the shares hard on that plan, then paused. BMO set a 52-week high of $187.22 USD in August and closed at $167.46 USD on October 16, 2026, still up about 27% year to date and 34% over one year but down about 6% over three months. Yahoo puts the market capitalisation near $116 billion USD. The August 10, 2026 agreement with RBC to sell the jointly owned Moneris payments business to Francisco Partners is still pending, and Q4 fiscal 2026 results are scheduled for December 2, 2026.

The bull case: what would have to be true for $182.39

The most optimistic published target on BMO is $182.39, +7.5% from the $169.74 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. The return-on-equity repair plan

At its Investor Day on March 26, 2026, BMO laid out a path to a sustained return on equity above 15% exiting fiscal 2027, bridged by roughly 250 basis points of core operating improvement on about 6% revenue growth per year, around 100 basis points from credit normalising, and around 50 basis points from share repurchases. Adjusted ROE went from 13.5% in Q2 fiscal 2026 to 14.0% in Q3, against 12.0% a year earlier, and year-to-date adjusted ROE was 13.3% against 11.1%. Reported ROE is noisier (11.1% year to date) because of the Stonepeak goodwill charge, but on an adjusted basis most of the gap to the target has closed.

2. Credit costs coming back down

Provision for credit losses was $722 million CAD in Q3 fiscal 2026, down from $797 million CAD a year earlier, and $2,207 million CAD year to date against $2,862 million CAD in the same period of fiscal 2025. The impaired provision of $708 million CAD fell $65 million on lower losses in Canadian P&C and U.S. Banking, while the performing-loan provision stayed small at $14 million CAD. Much of the earnings improvement so far is credit reverting toward a normal loss rate, though Q3 also showed revenue and fee growth doing more of the work.

3. US Banking as the swing factor

US Banking produced $868 million CAD of reported net income in Q3 fiscal 2026, or $620 million USD on a source-currency basis, up 11% in US dollars on a 5% revenue gain driven by higher net interest margin and fee income. Management targets a 12% ROE from the US segment by the fourth quarter of fiscal 2027. The Bank of the West integration is the reason BMO's consolidated returns fell behind peers, so the US segment carries most of the upside and most of the execution risk in the plan. Capital Markets was the standout in Q3, with net income up 46% to $645 million CAD.

4. Capital, buybacks and portfolio pruning

CET1 stood at 13.0% at July 31, 2026, comfortably above the OSFI requirement and down from 13.5% a year earlier mostly because capital is being returned. BMO repurchased 3.8 million shares for cancellation during Q3 at an average of $239.37 CAD and announced a new normal course issuer bid for up to 25 million shares, subject to OSFI and TSX approval. The quarterly dividend was held at $1.71 CAD, up 5% year over year. The pending Moneris sale to Francisco Partners is expected to add a gain of about $600 million CAD after tax and roughly 15 basis points of CET1 on closing, with BMO retaining an exclusive long-term referral arrangement rather than the operating business.

The bear case: what would have to be true for $144.51

The most pessimistic published target is $144.51, -14.9% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Bank of Montreal is worth if the risks below bite instead of the drivers above.

The largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in. The roughly 10% pullback from the August high shows how quickly that premium can shrink. Credit could turn again, and the Q2 improvement leaned on a near-zero performing-loan provision driven partly by model changes, which is not a repeatable source of earnings. Currency is a second, separate exposure: BMO earns and reports in Canadian dollars while the NYSE line is quoted in US dollars, so a weaker Canadian dollar reduces the US-dollar value of both the share price and the dividend regardless of how the bank performs. Reported results also carry deal noise: the $1.1 billion CAD pre-tax Stonepeak charge landed in fiscal Q3 and cut reported ROE to 8.4%, and the Stonepeak and Moneris sales still have to close. BMO also faces ongoing Canadian consumer litigation, including a $100 million CAD settlement of a long-running registered-plan fee class action, and a 2024 US plaintiff-firm press release announcing an investigation of potential securities claims, which as of August 2026 had not produced a filed securities class action complaint.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding BMO already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on BMO

3 analysts cover BMO, with an average target of $166.19 (-2.1% against $169.74) and a split of 4 buy, 7 hold, 3 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the BMO forecast and price target page.

How is BMO valued?

Market cap, P/E and dividend yield at today's price are in the BMO key stats above. The business figures below come from Bank of Montreal's reported results as of October 2026 and change when it next reports.

  • Reported net income (Q3 FY2026): ~$1.75B CAD, down 25% on a ~$1.1B pre-tax deal charge
  • Return on equity (Q3 FY2026): ~14.0% adjusted, ~8.4% reported
  • CET1 ratio (July 31, 2026): ~13.0%
  • Provision for credit losses (Q3 FY2026): ~$722M CAD, down from ~$797M CAD
  • Revenue (TTM): ~$35.7B CAD

As of October 2026: BMO closed at $167.46 USD on the NYSE on October 16, 2026, about 10% below its 52-week high of $187.22 USD and well above the low of $119.84 USD, for a market capitalisation near $116 billion USD. On Yahoo's figures the shares trade near 19 times trailing and 14 times forward earnings and about 2.0 times book, with a dividend yield near 2.9%. Consensus expects fiscal 2026 adjusted EPS of about $14.74 CAD, up about 21%, and Q4 fiscal 2026 results are scheduled for December 2, 2026.

How do you decide if BMO is a buy?

Whether BMO is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold BMO indirectly through an index or sector ETF before adding more.

What would change your mind on BMO

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: The return-on-equity repair plan stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: the largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the BMO stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BMO against your real portfolio and see your actual exposure before deciding.

Your questions about Bank of Montreal

Ask Walnut's AI anything about BMO and see how it fits what you own.

FAQ

Is BMO a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on The return-on-equity repair plan, with revenue (ttm) at ~$35.7B CAD. The bear case rests on the largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in. Analysts covering it are spread from $144.51 to $182.39, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell BMO?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $144.51, -14.9% from the $169.74 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for BMO?

+

The return-on-equity repair plan. At its Investor Day on March 26, 2026, BMO laid out a path to a sustained return on equity above 15% exiting fiscal 2027, bridged by roughly 250 basis points of core operating improvement on about 6% revenue growth per year, around 100 basis points from credit normalising, and around 50 basis points from share repurchases. The most optimistic analyst target on BMO is $182.39, +7.5% from the $169.74 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for BMO?

+

The largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in. The roughly 10% pullback from the August high shows how quickly that premium can shrink. Credit could turn again, and the Q2 improvement leaned on a near-zero performing-loan provision driven partly by model changes, which is not a repeatable source of earnings. Currency is a second, separate exposure: BMO earns and reports in Canadian dollars while the NYSE line is quoted in US dollars, so a weaker Canadian dollar reduces the US-dollar value of both the share price and the dividend regardless of how the bank performs. Reported results also carry deal noise: the $1.1 billion CAD pre-tax Stonepeak charge landed in fiscal Q3 and cut reported ROE to 8.4%, and the Stonepeak and Moneris sales still have to close. BMO also faces ongoing Canadian consumer litigation, including a $100 million CAD settlement of a long-running registered-plan fee class action, and a 2024 US plaintiff-firm press release announcing an investigation of potential securities claims, which as of August 2026 had not produced a filed securities class action complaint. The most pessimistic published target is $144.51, -14.9% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does Bank of Montreal do?

+

Canada's oldest bank, founded in 1817, spanning personal and commercial banking, wealth management and capital markets across Canada and the US Midwest.

What would have to change for BMO to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (The return-on-equity repair plan) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the largest near-term risk is valuation rather than fundamentals: at about 19 times trailing earnings and 14 times forward estimates on Yahoo's figures, BMO trades above the multiple Canadian banks have historically carried, and the shares are still up about 27% in 2026 in US dollar terms, so the ROE plan is substantially priced in) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Bank of Montreal actually do?

+

BMO is a diversified North American bank founded in 1817, with roughly $1.5 trillion CAD in total assets as of April 30, 2026. Revenue comes from five segments: Canadian personal and commercial banking, US banking (Chicago-centred and expanded by the 2023 Bank of the West acquisition), wealth management and insurance, capital markets, and a corporate services unit that holds treasury and unallocated items. About 55% of Q2 fiscal 2026 revenue was net interest income, with the rest fee-based.

Is BMO on the NYSE the same stock as BMO on the TSX?

+

Yes. Bank of Montreal has a genuine dual listing, with the identical common shares trading on both the Toronto Stock Exchange and the New York Stock Exchange under the ticker BMO. A US brokerage buys the ordinary Canadian share, not a depositary receipt, so there is no ADR sponsor and no ADR custody fee. The two lines track each other after adjusting for the CAD to USD exchange rate, and arbitrage keeps any gap small during overlapping trading hours.

Which currency are BMO's financial results in, and why does that matter?

+

BMO reports in Canadian dollars under IFRS. Its NYSE quote, market capitalisation as computed by US data providers, and any dividend a US broker credits are in US dollars. That split creates two distinct sources of return for a US holder: how the bank performs in Canadian dollars, and where the CAD to USD rate goes. The $6.84 CAD annual dividend shows up in Yahoo's data as about $4.81 USD per share in October 2026, and that US-dollar figure moves with the exchange rate even when the Canadian payout is unchanged.

Walnut is informational, not investment advice, and gives no verdict on BMO. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks